The prescription take up plus payment terms will result in most of the recent pharma sales living outside of the q3 report. Hopefully the action and revenue pipeline will have market appeal as I doubt the cold hard revenue will
knock knock, page-766
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.73M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4408 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 1899 | 2 |
View Market Depth
| Last trade - 16.12pm 08/11/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable